Conducting cancer control and survivorship research via cooperative groups: A report from the American Society of Preventive Oncology

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 5, 2011, Pages 1050-1055

  Palesh, Oxana ^a   Demark Wahnefried, Wendy ^b   Mustian, Karen ^c   Minasian, Lori ^d   Rowland, Julia ^d   Sprod, Lisa ^c   Janelsins, Michelle ^c   Peppone, Luke ^c   Sloan, Jeff ^e   Engquist, Karen Basen ^f   Jones, Lee ^g   Buist, Diana ^h   Paskett, Electra D ⁱ  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER AND LEUKEMIA GROUP B; CANCER CONTROL; CANCER PREVENTION; CANCER RESEARCH; CANCER SURVIVOR; CHILDREN ONCOLOGY GROUP; CLINICAL PROTOCOL; EASTERN COOPERATIVE ONCOLOGY GROUP; ECONOMIC ASPECT; GYNECOLOGIC ONCOLOGY GROUP; HEALTH CARE NEED; MEDICAL SOCIETY; NATIONAL HEALTH ORGANIZATION; NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT; NORTH CENTRAL CANCER TREATMENT GROUP; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RADIATION THERAPY ONCOLOGY GROUP; RESOURCE MANAGEMENT; SOCIAL NETWORK; SOUTHWEST ONCOLOGY GROUP; STAFF; STANDARDIZATION; SUNCOAST CCOP RESEARCH BASE AT THE UNIVERSITY OF SOUTH FLORIDA; UNIVERSITY OF ROCHESTER CANCER CENTER;

BIOMEDICAL RESEARCH; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; ORGANIZATIONAL INNOVATION; SURVIVAL RATE; SURVIVORS; UNITED STATES;

EID: 79955756909     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0176     Document Type: Article

References (16)

1. American Cancer Society. Cancer facts & figures 2010. Atlanta (GA: American Cancer Society; 2010.
2. Yeh ET. Cardiotoxicity induced by chemotherapy and antibody therapy. Annu Rev Med 2006;57:485-98. (Pubitemid 43262003)
3. Gralow JR, Biermann JS, Farooki A, Fornier MN, Gagel RF, Kumar RN, et al. NCCN Task Force Report: Bone health in cancer care. J Natl Compr Canc Netw 2009;7 Suppl 3:S1-32; quiz S33-5.
4. Michaud LB, Goodin S. Cancer-treatment-induced bone loss, part 1. Am J Health Syst Pharm 2006;63:419-30. (Pubitemid 43348392)
5. Michaud LB, Goodin S. Cancer-treatment-induced bone loss, part 2. Am J Health Syst Pharm 2006;63:534-46.
6. Verstappen CC, Heimans JJ, Hoekman K, Postma TJ. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 2003;63:1549-63. (Pubitemid 36976138)
7. Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst 2008;13:27-46. (Pubitemid 351393018)
8. Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002;20:485-93. (Pubitemid 34072533)
9. Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. BR J Cancer 2006;94:828-34.
10. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 2004;100:2292-9. (Pubitemid 38657875)
11. Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapyrelatedcognitive dysfunction:aninternationalperspective from the Venice cognitive workshop. Ann Oncol 2008;19:623-9. (Pubitemid 351461030)
12. Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 2001;19:895-908. (Pubitemid 32119105)
13. Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002;64:604-11. (Pubitemid 34791163)
14. Rowland JH, Glidewell OJ, Sibley RF, Holland JC, Tull R, Berman A, et al. Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia. J Clin Oncol 1984;2:1327-35. (Pubitemid 15179533)
15. Hamre MR, Robison LL, Nesbit ME, Sather HN, Meadows AT, Ortega JA, et al. Effects of radiation on ovarian function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. J Clin Oncol 1987;5:1759-65. (Pubitemid 18020840)
16. Ganz PA, Hussey MA, Moinpour CM, Unger JM, Hutchins LF, Dakhil SR, et al. Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897. J Clin Oncol 2008;10:1223-30.